Benazepril Hydrochloride/Hydrochlorothiazide

盐酸贝那普利/氢氯噻嗪

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBenazepril Hydrochloride/Hydrochlorothiazide
Drug Alias NameHydrochlorothiazide/Benazepril Hydrochloride氢氯噻嗪/盐酸贝那普利Benazepril Hydrochloride and Hydrochlorothiazide贝那普利氢氯噻嗪片Lotensin HCT
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsAngiotensin-converting enzyme inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1992/05/19
Country/TerritoryUnited StatesMainland China
CombinationsYes HydrochlorothiazideBenazepril Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesValidus PharmaceuticalsGuangzhou Nanxin Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BA07
Related LinksKEGG